169283 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for hepatitis Hepatitis B
Sub-classes:METHOD FOR MEASURING GLYCOSYLATED SURFACE ANTIGEN PROTEIN OF HBV
#2ANTI-RNA VIRUS PARTICLE ANTIBODY OF HBV
#3IN VITRO HBV CORE PROTEIN ASSAY
#4DETECTABLE ARRAYS FOR DISTINGUISHING ANALYTES AND DIAGNOSIS, AND METHODS AND SYSTEMS RELATED THERETO
#5USES OF 4210 DA PEPTIDE AS A MARKER IN DIAGNOSIS OF LIVER CANCER AND CIRRHOSIS
#6Method for efficiently inducing antibody, antibody and detection system for hepatitis virus
#7Method and means for the rapid detection of HDV infections
#8Antibodies and fragments thereof that bind hepatitis B virus protein X
#9METHOD FOR DETECTING THE QUANTITY OF BIOMARKER AND IDENTIFYING DISEASE STATUS
#10METHODS FOR SCREENING INFECTIONS
#11Methods of treating viral infection
#12ASSAY FOR DETERMINING HEPATITIS B CLEARANCE
#13Antibodies and fragments thereof that bind hepatitis B virus protein X
#14HBV antigen specific binding molecules and fragments thereof
#15Method for reduction of interferences in immunoassays
#16IMMUNOLOGICAL TEST KIT FOR EVALUATING VACCINE EFFICACY AND STORAGE METHOD THEREOF
#17Modulation of hepatitis B virus replication
#18Multiplex hepatitis B assay
#19Simultaneous analysis method for multiple targets using multiple metal nano-tags
#20METHOD FOR DETECTING THE QUANTITY OF BIOMARKER AND IDENTIFYING DISEASE STATUS
#21METHOD OF TREATING HEPATITIS B
#22Method for producing antibody reagent
#23RECOMBINANT HBV CCCDNA, THE METHOD TO GENERATE THEREOF AND THE USE THEREOF
#24Combo-Hepatitis Antigen Assays and Kits for Detection of Active Hepatitis Virus Infections
#25Pretreatment method of sample for detecting HBs antigen and use thereof
#26Multiplex hepatitis B assay
#27METHOD FOR PREDICTING THE RESPONSE OF A SUBJECT SUFFERING FROM A VIRAL INFECTION OF THE LIVER TO AN ANTIVIRAL THERAPY
#28Hepatitis B virus specific antibody and uses thereof
#29INTERFERON-ALFA SENSITIVITY BIOMARKERS
#30Assay for measuring plasma FGL-2 and methods and uses thereof
#31METHOD FOR DETECTION OF HEPATITIS B VIRUS
#32HBV precore protein capable of forming particles
#33METHOD FOR PREDICTING THE RESPONSE OF A SUBJECT SUFFERING FROM A VIRAL INFECTION OF THE LIVER TO AN ANTIVIRAL THERAPY
#34Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#35SERUM BIOMARKERS OF HEPATITIS B VIRUS INFECTED LIVER AND METHODS FOR DETECTION THEREOF
#36Three-dimensional structure of the APOBEC 2 structure, uses thereof, and methods for treating chronic and infectious diseases
#37Method for Detection of Hepatitus B Virus
#38Method of detecting hepatitis B virus s antigen
#39Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#40Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#41Method for Diagnosing Hepatic Diseases
#42METHODS FOR DIAGNOSING HEPATOCELLULAR CARCINOMA
#43Methods and means relating to hepatitis B infection
#44Variants of hepatitis B virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof
#45METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF VIRAL AND BACTERIAL INFECTIONS
#46HBV precore protein capable of forming particles
#47Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
#48Viral variants and uses therefor
#49Serum biomarkers of hepatitis B virus infected liver and methods for detection thereof
#50Method for predicting the severity of viral hepatitis type B in patients treated with an anti-viral agent, and a kit for diagnosing viral hepatitis type B